Purpose: This study aimed to determine whether aromatherapy inhalation would reduce chemotherapy-induced nausea and vomiting (CINV) among cancer patients receiving moderate to high emetogenic chemotherapy (HEC) regimen.
Methods: One hundred participants (control = 48; intervention = 52) receiving moderate to HEC treatment were enrolled in a two-arm control trial design. Participants in the control group followed physician-prescribed antiemetic treatment. Participants in the intervention group followed physician-prescribed antiemetic treatment and received an aromatherapy inhaler intervention for use at the first sign of CINV and as needed. Consented study participants were seen by a study team member over four time points during which the participants would complete the established instruments with scoring procedures and validity evidence.
Results: The use of the aromatherapy inhaler resulted in a reduction in CINV and antiemetic medication in the intervention group. The control group reported 522 instances of medication usage at visit one; 417 instances of medication usage at visit two; and 409 instances of medication usage at visit three. The intervention group reported 136 instances of medication use at visit one; 145 instances of medication use at visit two; and 142 instances of medication use at visit three. Similar to the patterns observed for pharmacological interventions, the control group also reported higher rates of the use of non-pharmacological interventions including tea, water/electrolytes, soup, and food compared to the intervention group.
Conclusion: The findings from this randomized clinical trial highlight the potential benefits of aromatherapy inhalation as a complementary therapy for managing CINV.
Purpose: Compassion fatigue (CF) and happiness at work (HW) are crucial determinants of well-being and performance among oncology professionals, who face high emotional demands. This study aimed to identify sociodemographic and professional predictors of CF and HW among oncology nurses and healthcare support workers.
Method: A cross-sectional observational study was conducted in the oncology inpatient departments of a hospital in northern Portugal. A total of 285 professionals participated by completing a self-administered questionnaire that included the Professional Quality of Life Scale and the Shortened Happiness at Work Scale. Multiple linear regression analyses were performed to identify predictors of CF and HW dimensions.
Results: Leisure activities and older age were found to be protective factors against CF. Working in emotionally demanding departments, such as Bone Marrow Transplant and Paediatrics, was associated with higher levels of burnout and secondary traumatic stress. Fixed work schedules and participation in leisure activities predicted greater job satisfaction and organisational commitment. The regression models accounted for 11 %-16 % of the variance in CF and HW dimensions.
Conclusions: Both individual and workplace factors significantly influence oncology professionals' well-being. Interventions that encourage leisure activities, promote balanced work schedules, and foster supportive work environments can help reduce CF and enhance HW. These strategies may contribute to healthier, more resilient, and sustainable oncology care teams.

